FAST-CR (Fragmented Autoantigen Stimulated T-cell-immunotherapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FAST-CR (Fragmented Autoantigen Stimulated T-cell-immunotherapy), covering 2025-03-12 to 2025-03-12. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR) [EARLY_Phase 1]